Related Experiment Video
Updated: May 5, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.1K
Percutaneous mechanical circulatory support for acute right heart failure: A practical approach
Mario Gramegna1, Christophe Vandenbriele2,3, Guido Tavazzi4,5
1Cardiac and Cardiac Surgery Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
ESC Heart Failure
|April 21, 2025
Summary
Percutaneous right ventricular assist devices (pRVADs) offer critical hemodynamic support for acute right heart failure refractory to standard treatments. This review details their use, patient selection, and management strategies for improved outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
- Medical Devices
Background:
- Acute right heart failure (RHF) is a serious condition with high mortality.
- Conventional treatments are often insufficient for severe RHF.
- Percutaneous right ventricular assist devices (pRVADs) are emerging as a key therapy.
Purpose of the Study:
- To review the role of pRVADs in managing acute RHF.
- To outline patient selection, device implementation, and weaning strategies.
- To discuss challenges, complications, and future directions in pRVAD therapy.
Main Methods:
- Review of contemporary evidence and expert consensus on pRVADs.
- Analysis of hemodynamic assessment using pulmonary artery catheterization and echocardiography.
- Discussion of clinical scenarios, complications, and management protocols.
Main Results:
- pRVADs provide targeted hemodynamic support in diverse RHF etiologies.
- Meticulous assessment and monitoring are crucial for successful pRVAD implementation.
- Effective weaning strategies focus on RV recovery and hemodynamic stabilization.
Conclusions:
- pRVADs are a vital option for refractory acute RHF.
- A multidisciplinary approach and further innovation are needed for optimal outcomes.
- This review offers a framework for clinical decision-making in pRVAD therapy.
More Related Videos
Related Concept Videos
01:21Cardiac Catheterization II: Right Heart Catheterization
2.2K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
2.2K
01:30Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
01:22Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753